
| e-pharmalink June 2009 |
|
e-Pharmalink is an electronic newsletter of the Ecumenical Pharmaceutical Network (EPN), an independent, non-profit Christian organization, whose mission is to support churches and church health system provide and promote just and compassionate quality pharmaceutical services through networking, access to medicine and treatment literacy programmes. This newsletter aims at equipping pharmacists and other health professionals with information about international trends relevant to their work and opportunities that could support them in their efforts to provide effective and efficient services, particularly in poor countries. It is a summary of news reported by a wide range of publications or organizations and includes web links to the original sources. Anyone can receive this e-mail NEWSHiv and Aids TreatmentOver 3000 children diagnosed with HIV in Lusaka after hospital introduces opt-out HIV testingImplementing a policy of routine opt-out HIV testing led to the diagnosis of 3000 HIV infections in children admitted to hospital in Lusaka over an 18-month period, investigators report in a study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. http://www.aidsmap.com/en/news/5727979B-DD27-4949-9BAE-3D47A6F462B5.asp HIV treatment should be started earlier in resource-limited settings HIV Prevention efforts and infection patterns mismatched Antimicrobial Resistance and Infection ControlResistant tuberculosis worrying Bacteria photo shows role of hand hygiene in hospitals Swiss researchers have found that 84% of individuals with newly-diagnosed HIV who were infected with a strain of the virus resistant to antiretroviral drugs were part of transmission clusters composed only of other newly diagnosed individuals. The study, which is published in the online edition of AIDS also found that 9% of recently diagnosed individuals were infected with a drug-resistant strain of HIV, and that 53% of individuals with recent HIV infection could be linked to a transmission cluster. “Newly diagnosed, untreated individuals are a significant source of resistant strains, thus suggesting an important self-fueling mechanism for transmitted drug resistance”, write the investigators. http://www.aidsmap.com/en/news/B486A11A-0022-4C7D-84AD-4BD859BA6C1B.asp Plant Microbe Shares Features with Drug-Resistant Pathogen An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology. http://www.bnl.gov/bnlweb/pubaf/pr/PR_display.asp?prID=946 OthersPeople’s health movement secretariat moves to Cape Town, South AfricaFrom 1 June 2009, the PHM Global Secretariat will be hosted by PHM-South Africa in Cape Town, South Africa. For the last three years, from June 2006 to June 2009, PHM’s Global Secretariat has been based in Cairo at the Association of Health and Environment Development (AHED). Cape Town will be the fourth location of the PHM Global Secretariat. From January 2000 to December 2002, the Secretariat was hosted by Gonoshasthaya Kendra in Savar, Bangladesh, from January 2003 – May 2006 in Bangalore, India, hosted by the Community Health Cell. http://phmovement.org/cms/en/node/2010 2008 International Drug Price Indicator Guide Available Management Sciences for Health (MSH) announce the availability of the 2008 edition of the International Drug Price Indicator Guide. The Guide provides a spectrum of prices from 25 sources, including pharmaceutical suppliers, international development organizations, and government agencies. http://erc.msh.org/dmpguide/pdf/DrugPriceGuide_2008_en.pdf Guidelines for Field Surveys of the Quality of Medicines Evidence suggests that a significant proportion of drugs consumed in the developing world are of poor quality .Translating evidence on drug treatment outcomes into treatment policy is futile if the medicines actually used have substantially inferior efficacy compared with the medicines originally evaluated. http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000052 RESOURCESTraining opportunities i+solutions offering training on management of pharmaceutical supplies PublicationsThe costly access to essential medicines in Kenya: Voices of consumers on affordability and availability New Publication on Medicine Prices Issues Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs |